Status:

UNKNOWN

High-definition Transcranial Electrical Stimulation for Lower Limb Stroke Rehabilitation

Lead Sponsor:

Taipei Medical University Hospital

Conditions:

Stroke

Eligibility:

All Genders

20+ years

Phase:

NA

Brief Summary

Transcranial electrical stimulation (tCES) is a non-invasive and safe treatment, which uses a low direct current or alternating current to change the excitability of the cerebral cortex. The tCES has ...

Eligibility Criteria

Inclusion

  • With a diagnosis of stroke.
  • Age ≥ 20 years.
  • Hemiplegia, Brunnstrom stage III-V.
  • 6 months to 5 years after stroke.
  • Muscular inelasticity (spasticity) 1-3 on the affected lower limb, evaluated by the Modified Ashworth Scale.
  • Ability to walk for 10 min non-stop with no gait aids or ability to walk 20 m with supervision or slight assistance.

Exclusion

  • Intolerance to electrical stimulation.
  • Contracture on lower extremities, and limitation in joint range of motion.
  • Severe spasticity.
  • Ossification or inflammation in muscle tissue.
  • A history of arrhythmia.
  • Implantable medical electronic devices (e.g., like pacemaker).
  • Metal implants in the head or neck.
  • Wounds on the skin of head.
  • A history of brain surgery or severe brain trauma.
  • Severe cognitive or psychiatric disorders (e.g., schizophrenia, depression or bipolar disorder).
  • A history of seizure or other brain pathology.
  • Drug or alcohol abuse.
  • Malignant neoplasm or rheumatism disorder (e.g., SLE, RA, AS, IBD)
  • Undergoing other non-invasive brain stimulation.
  • Intra-cerebral lesions (such as brain tumors, arteriovenous tumors).
  • History of encephalitis or meningitis.
  • Stroke lesion in cerebellum or brainstem.
  • Leg amputation.
  • Sleep deprivation.
  • Severe or recent heart disease.
  • Subjects who use drugs that may lower the seizure threshold.
  • Pregnant or breastfeeding women.

Key Trial Info

Start Date :

August 20 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2023

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT04515121

Start Date

August 20 2020

End Date

December 31 2023

Last Update

January 31 2023

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

New Taipei City, Taiwan, 235

2

Taipei Medical University Hospital

Taipei, Taiwan, 110

3

Taipei Municipal Wanfang Hospital - Taipei Medical University

Taipei, Taiwan, 116